Siemens gets FDA nod for Biograph Horizon Flow

2017 06 12 13 09 34 718 Siemens Biograph Horizon Flow Pet Ct 20170612201123

Siemens Healthineers has received U.S. Food and Drug Administration (FDA) clearance for its Biograph Horizon Flow PET/CT scanner.

Horizon Flow features Siemens' FlowMotion continuous bed motion scanning technology, which was initially introduced on the company's premium Biograph mCT Flow PET/CT platform in 2013. FlowMotion enables institutions to configure personalized exam protocols based on patient anatomy, according to the vendor.

Users can define up to four distinct scanning regions, each with a different bed speed, Siemens said. What's more, specific exam reconstructions can be applied to each scanning region or to multiple regions, and the scanner can also facilitate high-resolution reconstructions and respiratory gating.

The Biograph Horizon Flow PET/CT scanner. Image courtesy of Siemens Healthineers.The Biograph Horizon Flow PET/CT scanner. Image courtesy of Siemens Healthineers.

Siemens has also migrated its HD-Chest technology to Biograph Horizon Flow. Previously available only on the firm's Biograph mCT PET/CT line, HD-Chest acquires and processes motion-frozen chest scans five times faster than standard respiratory gating techniques, the vendor said.

The company is targeting Biograph Horizon Flow at progressive community hospitals, as well as satellite campuses of large healthcare networks.

Page 1 of 435
Next Page